• EU green light for Cimzia to treat psoriasis pharmatimes
    July 04, 2018
    The European Medicines Agency has approved a label extension for UCB’s Cimzia allowing its use to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.
PharmaSources Customer Service